P
31.22
-0.12 (-0.38%)
| Previous Close | 31.34 |
| Open | 31.37 |
| Volume | 230,036 |
| Avg. Volume (3M) | 1,722,588 |
| Market Cap | 4,889,524,224 |
| Price / Earnings (TTM) | 29.73 |
| Price / Earnings (Forward) | 6.31 |
| Price / Sales | 0.980 |
| Price / Book | 5.53 |
| 52 Weeks Range | |
| Earnings Date | 7 Nov 2024 |
| Profit Margin | 2.59% |
| Operating Margin (TTM) | 0.07% |
| Diluted EPS (TTM) | 0.610 |
| Quarterly Revenue Growth (YOY) | 29.10% |
| Quarterly Earnings Growth (YOY) | 30.70% |
| Total Debt/Equity (MRQ) | 469.36% |
| Current Ratio (MRQ) | 1.71 |
| Operating Cash Flow (TTM) | 99.08 M |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | PACS Group, Inc. | Bullish | Bearish |
AIStockmoo Score
-0.1
| Analyst Consensus | 1.5 |
| Insider Activity | -3.0 |
| Price Volatility | -3.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 4.0 |
| Average | -0.10 |
|
PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Core |
| % Held by Insiders | 72.29% |
| % Held by Institutions | 29.86% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Crewe Advisors Llc | 30 Sep 2025 | 1,112,068 |
| 52 Weeks Range | ||
| Median | 33.00 (5.70%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| RBC Capital | 20 Nov 2025 | 33.00 (5.70%) | Buy | 26.14 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| DILSAVER EVELYN S | 29.96 | - | 16,724 | 501,051 |
| MITCHELL JOHN TODD | - | 29.96 | -159,556 | -4,780,298 |
| Aggregate Net Quantity | -142,832 | |||
| Aggregate Net Value ($) | -4,279,247 | |||
| Aggregate Avg. Buy ($) | 29.96 | |||
| Aggregate Avg. Sell ($) | 29.96 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| MITCHELL JOHN TODD | Officer | 24 Nov 2025 | Sell (-) | 159,556 | 29.96 | 4,780,298 |
| DILSAVER EVELYN S | Director | 24 Nov 2025 | Buy (+) | 16,724 | 29.96 | 501,051 |
| Date | Type | Details |
|---|---|---|
| 01 Dec 2025 | Announcement | PACS Group Announces Business Updates |
| 19 Nov 2025 | Announcement | PACS Group, Inc. Reports Third Quarter 2025 Results |
| 17 Nov 2025 | Announcement | PACS Group Intends to Release Third Quarter 2025 Earnings and Submit SEC Filings on November 19, 2025 |
| 11 Sep 2025 | Announcement | PACS Group Announces NYSE Listing Extension and Provides Select Preliminary Interim Operating Metrics |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |